Adipose-Derived Stem Cells for Knee Osteoarthritis
This study is looking at how well a treatment using Adipose-Derived Stem Cells (stem cells from your own fat) works for knee osteoarthritis. Researchers want to compare this treatment, which involves taking fat cells and putting them into your knee after standard arthroscopic surgery (a type of keyhole surgery for joints), to standard arthroscopic surgery alone. They hope the stem cells might help repair tissue and reduce inflammation. You could be eligible if you are between 35 and 70 years old and are scheduled for certain knee procedures like meniscal debridement or chondroplasty. The main goal is to see if adding stem cells improves your knee function and pain scores (KOOS score) 24 months after surgery. The study is currently unclear on its recruitment status and plans to enroll 29 participants.
- Study design
- This is an interventional study comparing two treatment groups for knee osteoarthritis. It plans to enroll 29 participants.
- What's involved
- Participants will undergo either arthroscopic debridement with stem cell transplantation or arthroscopic debridement only. Follow-up will continue for 24 months after surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 24 months after surgery to assess their KOOS score.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
At a glance
Conditions
NCT03014401
Where you'd take part
This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Kerlan Jobe Orthopedic Institute
Santa Monica, Californiastudy coordinator listed
Recruiting
UC Health Steadman Hawkins Clinic - Denver Inverness
Denver, Coloradostudy coordinator listed
Recruiting
Stanford University
Stanford, Californiano site contact published
Active, not recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Jason L Dragoo, MD · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver
- Seth L Sherman, MD · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Postoperative KOOS (Knee Injury and Osteoarthritis Outcome Score) score 24 months following surgeryThe study will end after 24 month follow-up is completed in all participants.
Patient reported outcomes measures; Score ranges 0-100, with 100 being healthy/normal